RCMI Coordinating Center (RCMI CC) Header Logo

?-Aminobutyric acid type A receptor inhibition triggers a nicotinic neuroprotective mechanism.

Ferchmin PA, P?rez D, Castro Alvarez W, Penzo MA, Maldonado HM, Eterovic VA. ?-Aminobutyric acid type A receptor inhibition triggers a nicotinic neuroprotective mechanism. J Neurosci Res. 2013 Mar; 91(3):416-25.

View in: PubMed

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support